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Abstract
The ontogeny of neural crest cells (NCC) involves a number of orchestrated variety of derivatives, including components of the
peripheral nervous system and melanocytes. Thus, it represents an excellent model system to investigate mechanisms controlling
epithelial–mesenchymal transitions, cell migration and differentiation, as well as cell proliferation and death. We have established a new
transgenic line expressing the Cre recombinase under the control of the human tissue plasminogen activator promoter (Ht-PA). The activity
of the reporter in the Ht-PA-Cre/R26R embryos is observed as early as Theiler stage 12 in the cephalic mesenchyme. Later, the targeted
cells include all the known derivatives of cranial, vagal, and trunk NCC, including craniofacial structures and cranial ganglia, cardiac and
endocrine derivatives, melanocytes, peripheral, and enteric nervous system. At the vagal level, the location of presumptive enteric NCC
differs from their avian counterparts in their ability to invade the mesenchyme lateral to the neural tube. In contrast to the Wnt1-Cre line,
the Ht-PA-Cre line does not target the central nervous system and therefore renders it more specific for NCC. Our Ht-PA-Cre mice represent
a novel model to specifically target conditional mutations in migratory NCC.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Neural crest cells (NCC) are induced at the dorsolateral
edge of the neural plate during early embryogenesis. They
undergo an epithelium-to-mesenchyme transition, delami-
nate from the neural tube (NT), and migrate in the embryo
to reach target sites where they differentiate into a variety of
derivatives (Le Douarin and Kalcheim, 1999). Complemen-
tary approaches, such as grafting experiments, tracing with
dye labeling, or retrovirus insertion coupled with the anal-
ysis of marker expression, have been used extensively in
chick, frog, and zebrafish to define the fate of NCC
(Weston, 1963, 1991; Le Douarin, 1982; Thiery et al., 1982;
Jesuthasan, 1996; Serbedzija et al., 1989, 1990; Collazo et
al., 1993; Eisen and Weston, 1993). In addition, the cellular
and molecular mechanisms underlying the induction, mi-
gration, and differentiation processes of NCC have been
investigated by using gene transfer and perturbation exper-
iments (reviewed in Christiansen et al., 2000; Garcia-Castro
and Bronner-Fraser, 1999; Anderson, 1999). Genomic tech-
nologies in mice offer the possibility to turn on or off
expression of specific genes and determine their function in
embryogenesis (Lewandoski, 2002). In particular, trans-
genic mice expressing Cre recombinase under the control of
spatiotemporally regulated promoters are powerful tools to
promote a conditional deletion of floxed genes (Kilby et al.,
1993). A growing number of transgenic Cre-lines are being
established (Nagy, 2000), among which some are poten-
tially useful to create conditional mutations in NCC and
their derivatives (Danielian et al., 1998; Li et al., 2000;
Yamauchi et al., 1999; Feltri et al., 1999; Voiculescu et al.,
2000). However, until now, a specific targeting of NCC had
not been achieved.
In the present study, we have produced and characterized
a new transgenic mouse line in which the transgene is
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specifically targeted to NCC. This line expresses the Cre re-
combinase under the control of the 3-kb fragment of the human
tissue plasminogen activator (Ht-PA) promoter. This promoter
was chosen because it has been reported to drive -galactosi-
dase expression in a spatiotemporally regulated manner in
various NC-derivatives in E10.5–E14 transgenic Ht-PA-LacZ
embryos (Theuring et al., 1995). In Ht-PA-Cre/R26R embryos,
the earliest -galactosidase expression is observed at Theiler
Stage 12 (E8) in NCC-derived cephalic mesenchyme. At
E16.5 and in the adult, the labeled cells correspond to all the
known derivatives of NCC, including cardiac derivatives, the
enteric nervous system, the peripheral nervous system, the
endocrine derivatives, and melanocytes. We have analyzed the
location of NCC during the early steps of their migration to
colonize the gut. Later, the enteric ganglion networks display
specific organization throughout the developing gut, which is
maintained in the adult. Our Ht-PA-Cre mice and the Wnt1-
Cre mice, described previously (Danielian et al., 1998; Chai et
al., 2000; Jiang et al., 2000, 2002), target the NCC derivatives
similarly. However, in contrast to the Wnt1-Cre, the Ht-PA-
Cre mice do not target cells in the dorsal NT. The NCC were
labeled only as they begin to migrate, but not before they
undergo their epithelial-to-mesenchymal transition. This new
transgenic line constitutes an extremely valuable tool to target
the conditional mutation of a gene of interest in the NCC at the
onset of their migration and subsequently in their derivatives.
Furthermore, it can also be used as a tool to mark NCC for
various purposes, such as lineage tracing. Finally, this line is
useful to elucidate molecular mechanisms underlying NCC
ontogeny.
Materials and methods
Plasmid construction
The Ht-PA-Cre vector was constructed by fusing the
proximal 3 kbp of the human tissue plasminogen activator
promoter (Ht-PA) upstream to the Cre recombinase coding
sequence. The plasmid pBS185 (Gibco–Life Technologies)
carrying the CMV promoter, the Cre recombinase coding
sequence, and the mouse MT-1 polyadenylation site was
digested by SpeI and XhoI to eliminate the CMV promoter
sequence. The overhangs were blunt ended by Klenow en-
zyme and religated to produce pBS185*, where the SpeI
was recreated at the ligation site. The pBS185* was then
digested by SpeI and filled in by the Klenow enzyme. The
Ht-PA-lacZ plasmid (Theuring et al., 1995) was digested by
XbaI and HindIII to obtain a fragment containing 2956 bp of
the Ht-PA promoter, the first exon (1–132 bp), and the first
intron sequence up to 358 bp. After filling in the overhangs,
this fragment was cloned into the blunt-ended pBS185*.
The 7.3-kb transgene fragment (Fig. 1) was obtained by
HincII and KpnI digestion and used to produce transgenic
mice as described previously (Faraldo et al., 1998).
Production of transgenic mice
The genomic DNA prepared from tail biopsies of 4-week
pups was tested for the insertion of the transgene by PCR
analysis using the sense (5-TGTCTCCTCTTCTT-
TCTCTTA-3) and the antisense (5-CGCCTGAA-
GATATAGAAGATA-3) oligonucleotides, which map in
the Ht-PA first intron and in the Cre recombinase coding
sequence, respectively. Eleven transgenic animals were se-
lected based on the presence of the 427-bp amplicon. The
Cre recombinase expression in the transgenic animals was
tested by using the ROSA26 Cre reporter (R26R) mice as
follows. The transgenic males were crossed with R26R
females. The founder transgenic females were crossed with
wild type males, and the corresponding F2 transgenic males
were then crossed with R26R females. The morning of
appearance of a vaginal plug (day 0) was considered E0.5,
Fig. 1. Structure of the transgene used to produce transgenic animals and
the corresponding mRNA produced.
Fig. 2. Early Ht-PA-Cre-dependent expression of the -galactosidase re-
porter during mouse embryogenesis. In whole-mount stained Theiler Stage
13 (A), early Stage 14 (B and C), Stage 14 (D), and Stage 15 (E) embryos,
and in sagittal section (C), labeled cells are found around the optic pit (red
arrowhead) and in the first and second branchial arches (black arrowheads).
In E9.5 embryos, an intense staining is observed in these sites and around
the otic placode. More caudally, cells in the third forming branchial arch
could be seen. (F and G) Transverse sections of a Stage 15 embryo,
respectively. In (F), mesenchymal cells known to be of NCC origin are
heavily stained in the first and second branchial arches, whereas the
pharyngeal endoderm and ectoderm (black arrow) as well as few meso-
dermal cells (red arrow) that are not derived from NCC are not labeled. In
(G), stained cells are seen lateral to the NT and in ventral position, in
known NCC pathways. The neural tube itself is not labeled (arrow in C and
G). (B) and (F) are at the same magnification as (A) and (G), respectively.
Scale bar in (A), (D), and (E) corresponds to 500 m. Scale bar in (C) and
(G) corresponds to 200 m.
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Fig. 3. Ht-PA-Cre-dependent -galactosidase expression in E12.5 embryos in cephalic and sensory derivatives. (A) Whole-mount staining of an embryo
shows intense staining of craniofacial structures and peripheral nervous system. Sections of the head showing the mandibular process (B), the forming eye
(C), the cephalic mesenchyme (D), and the trigeminal and vestibulocochlear ganglia (E). (F) Double staining for -galactosidase (blue) and with an antibody
recognizing placodal neurons and directed against Brn-3a antibody (brown) show that glial cells of the vestibulocochlear ganglia are targeted by the transgene
but not the neurons from placodal origin. In (D), black arrowhead, red arrowheads, and black arrow, respectively, indicate the labeling of the ectoderm of
the face, the ectomenix, and the cells associated with the vasculature of CNS that corresponds to pericytes. Lateral view (G) of the whole-mount stained E12.5
embryo and a 200-m-thick transverse section (H) showing the subcutaneous and muscular sensory innervation network. Sagittal section of a E12.5 embryo
where sympathetic and dorsal root ganglia appear heavily stained (I). Arrowheads and arrows in (H) and (I) show the dorsal and ventral roots, respectively.
nc, nasal cavity; tg, trigeminal ganglia; vch, vestibulocochlear ganglia; il, internal layer; l, lens; ce, corneal epithelium; hc, hyaloid cavity; tv, telencephalic
ventricule; cm, cephalic mesenchyme; drg, dorsal root ganglia; sg, sympathetic ganglia; vr, ventral ramus; dr, dorsal ramus; mi, muscular innervation; ci,
cutaneous innervation; ca, cutaneous anterior ramus; cl, cutaneous lateral ramus. Scale bar in (A), (C), and (G) corresponds to 1 mm. Scale bar in (D), (B),
(H), and (I) corresponds to 200 m. Scale bar in (E) and (F) represents 100 m.
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and the pregnant females were sacrificed by cervical dislo-
cation at E8–E16.5.
Among the 11 founders, 9 animals produced embryos
expressing -galactosidase in NCC-derived tissues. Among
them, the male founder #116 was selected for further anal-
ysis on the basis of the specific expression of the reporter
gene observed in E11.5–E12 embryos in NCC-derived tis-
sues, such as craniofacial structures and peripheral nervous
system.
The Ht-PA-Cre mouse line was generated by mating a
founder (#116) to wild type females and then by intercrosses
and backcrosses of the offspring to obtain homozygous ani-
mals. Wnt1-Cre mice were provided by A. McMahon (Danie-
lian et al., 1998). Transgenic Ht-PA-Cre or Wnt1-Cre males
were mated with R26R females to produce embryos and pups.
Ht-PA-Cre/R26R and Wnt1-Cre/R26R embryos were col-
lected at defined stages of development. E8–E10 embryos
were fine staged according to the Theiler stage table (Theiler,
1989). Newborn mice from the same type of crosses were
staged according to the date of birth (P0).
Embryo processing and detection of the -galactosidase
in tissue
Embryos or organs were dissected in cold phosphate-
buffered saline (PBS), pH 7.6, with 5% fetal calf serum and
fixed in toto in freshly made ice-cold 1% formaldehyde/
0.2% glutaraldehyde/0.02% Nonidet-P40 for 2–4 h. The
detection of -galactosidase activity was revealed at 30°C
by a 16- to 20-h whole-mount X-gal staining as described
before (Dufour et al., 1994). Whole-mount stained samples
were photographed under a Leica MZ8 stereomicroscope
(Leica Microsystemes SA, France) equipped with a JVC
3CCD color camera. Some whole-mount stained embryos
were serially sectioned at a thickness of 200 m on a
vibratome. For histological sections, embryos or tissue were
dehydrated and embedded in paraplast Plus and cut into
serial sections of 7–10 m. Sections were processed and
slightly counterstained with eosin, nuclear fast Red, or the
van Gieson solution (for the adult skin and gut sections; see
van Gieson, 1889).
Antibodies and immunohistochemistry
Polyclonal antibodies directed against chromogranin A
 B were purchased from Progen Biotechnik (Germany).
The anti-Hu antibody was a gift of J. Weston (Marusich and
Weston, 1992). The antibody directed against Brn-3a was a
gift of E. Turner (Artinger et al., 1998). Sections were
dewaxed and processed for antigen retrieval by boiling in
citrate buffer for 20 min and then kept at room temperature
for 30 min. Sections were treated with 3% hydrogen per-
oxide in PBS containing 0.1% Tween 20 (PBST) for 1 h,
rinsed several times in PBST, and blocked for 2 h in block-
ing solution containing 0.5 Blocking Reagent (Roche Ap-
plied Science, France) and 10% fetal calf serum in PBST.
The sections were then incubated overnight at 4°C with
primary antibody (anti-chromogranin A  B, 1:50; anti-
Brn-3a, 1:500) in the blocking solution, rinsed several times
in PBST, and incubated with anti-rabbit-HRP (1:100; Am-
ersham Biosciences Europe, France) for 2 h at room tem-
perature prior to revealing the HRP activity using the per-
oxidase substrate kit VECTOR according to manufacturer
instructions (Vector Laboratories, Inc.).
Results
We have characterized the spatiotemporal pattern of the
Ht-PA-Cre activity by examining the -galactosidase stain-
ing in the Ht-PA-Cre/R26R offspring at various stages of
their embryonic development and postnatally. Six genera-
tions were analyzed for -galactosidase expression. Over all
these generations, the expression pattern remained as de-
scribed below, indicating that the expression of the trans-
gene is stable.
Early activation of the Ht-PA promoter during
development and expression of -galactosidase in various
NCC derivatives
The earliest expression of -galactosidase was seen at
Theiler Stage 12. By Stage 13, labeled cells were found in
the mesenchyme of the first pharyngeal arch, in the fronto-
nasal region and around the optic pit (Fig. 2A). The number
of labeled cells increased with time of development. Ex-
pressing cells were found in the second and third pharyngeal
arches and into the other arches from Stage 13 to 15 (Fig.
2B–E). In transverse sections, most of the mesenchymal
cells in pharyngeal arches were clearly labeled, but not the
pharyngeal ectoderm and endoderm (Fig. 2F). Some unla-
beled cells in the center of the pharyngeal arch correspond
to mesodermally derived cells (Fig. 2F; and Noden, 1978).
At that stage, at both the rostral and caudal levels, cells that
emerge from the neural tube and are distributed in the
ventral pathway were labeled (Fig. 2G). The NT does not
express the -galactosidase.
At E12.5 and later, -galactosidase was heavily ex-
pressed in craniofacial structures and the sensory nervous
system (Fig. 3A). In the head, the maxillary (Fig. 3B) and
mandibular process, the perioptic mesenchyme, the cells
that will form the cornea and iris (Fig. 3C), and the cells
located in the hyaloid cavity were labeled. The cephalic
mesenchyme surrounding telencephalic vesicle and the di-
encephalon were intensively stained for -galactosidase
(Fig. 3D). These cells produce pericytes of CNS and the
outer table of ectomenix (arrow and red arrowhead, respec-
tively) as well as the dermis of the face (black arrowhead).
In addition, labeled cells were found in various sensory
cranial ganglia, such as the vestibulocochlea and trigeminal
ganglia (Fig. 3E) as well as the ciliary and nodose ganglia
and the corresponding nerves (not shown). The labeled cells
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in the vestibulocochlear ganglia are glial cells (presumably
of neural crest origin) which surround Brn-3a-positive neu-
rons (presumably of placodal origin), which do not express
-galactosidase (Fig. 3F). In the trigeminal ganglia, we
observed that most of the cells are labeled for -galactosi-
dase (Fig. 3E). A large part of the labeled cells expressed
the Hu protein, a marker of early neuronal differentiation
(Marusich and Weston, 1992), whereas others are negatives
(not shown). This result indicates that the labeled cells
contribute to the neuronal and glial compartments of the
trigeminal ganglia, which probably derived mainly from
NCC. However, some Brn-3a-positive cells did not express
-galactosidase, suggesting that few neurons from placodal
origin may also contribute to the trigeminal ganglia. This
supports the possibility of dual origin of neurons in the
trigeminal ganglia.
In the trunk, in whole-mount preparations (Fig. 3G) and
on 200-m-thick transverse sections (Fig. 3H), the devel-
oping muscular and cutaneous innervation corresponding to
the primitive spinal nerve trunk were visible. They first
separate into primary dorsal and ventral ramus and then into
lateral and anterior branches. In all these structures, the glial
cells located along the sensory and motor nerves were
strongly labeled. The spinal ganglia and sympathetic gan-
glia (Fig. 3I) were homogenously stained, revealing that
both glial and neuronal precursors were labeled in these
structures. Cells in the central and peripheral roots of spinal
ganglia as well as the ventral root of the spinal cord were
also positive for -galactosidase expression (Fig. 3H and I,
arrows). At higher magnification, the staining observed on
ventral roots corresponds to the glial cells (NCC-derived)
associated with the axons, whereas the motor neurons and
their axons were not labeled (not shown).
Ht-PA-Cre-dependent expression of -galactosidase in the
enteric nervous system
At Theiler Stage 15 (E9.75), from the cranial level to the
first and second somites formed, labeled cells were found
close to the NT and located laterally between the ectoderm
and the condensing cervical myotome (Fig. 4B, arrows).
They were also found in the space between the endoderm of
the pharynx and the splanchnic mesoderm (Fig. 4A, ar-
rows), between the myotome and the NT and in the pha-
ryngeal pouch (Fig. 4C); but the labeled cells were never
found in the perichordal mesenchyme (arrowhead in Fig.
4A). -Galactosidase-expressing cells were closely apposed
to the lateral and ventral parts of the left and right dorsal
aorta (Fig. 4C–F, arrowheads). Others were found entering
the primitive gut (Fig. 4E and F, arrows). Sections from
several Theiler Stage 15 embryos were analyzed for the
presence of labeled cells, and a schematic representation of
their localization is shown in Fig. 4G. At E12.5, labeled
cells were found in the developing gut (Fig. 5A). At that
stage, they were present in the descending colon and the
front of their migration is easily seen (arrow). Labeled cells
were also seen in the pelvic mesenchyme at the level of the
cecum (arrowhead). By E16.5, the whole gut contains la-
beled cells which were organized into interconnected gan-
glia, characteristic of the enteric nervous system (Fig. 5B
and D, and for review, see Gershon et al., 1993). On trans-
verse sections of an E16.5 gut, the -galactosidase staining
corresponds to ganglia located in the outer layer of the wall
(Fig. 5C and E). Few positive ganglia were also seen in a
submucosal position at this stage. In the adult gut, whole-
mount staining revealed the organization and density of
enteric ganglia which differ in the proximal part and the
distal part of the gut (not shown), as previously observed
(Furness et al., 1987). At the level of the jejunum, an
intermediate density of labeled aggregates with thin inter-
connections are shown (Fig. 5F) which correspond to the outer
myenteric (Fig. 5G, arrows) and inner submucosal ganglia
(Fig. 5G, arrowheads) as shown on transverse section.
Ht-PA-Cre-dependent expression of -galactosidase in the
heart and other derivatives
-Galactosidase-labeled cells were present along the
endoderm in the aortic sac at Theiler Stage 15 (Fig. 6A,
arrow). At E12.5, labeled cells were found surrounding the
thymus primordium, forming the wall of innominate artery,
aorta, and ductus arteriosis (Fig. 6B and C). At E16.5 (Fig.
6D) and in the adult (Fig. 6E and F), the -galactosidase
staining was found in the outflow tract of the heart, a site
where the presence of NCC has recently been confirmed
(Jiang et al., 2000). Parasympathetic innervation and sen-
sory ganglia of the heart were labeled as shown on whole-
mount E16.5 and adult heart (Fig. 6D and F, black arrow).
On transverse sections of a E16.5 heart, the subendothelial
layer of the pulmonary trunk septum and the aortic valve
were heavily stained as well as scattered cells in the inter-
ventricular septum. The endothelium was not labeled, nor
was the wall of the aorta, as previously described (arrow in
Fig. 7E; and Jiang et al., 2000). In the adult, extensive
staining of the ascending aorta was observed as well in the
innominate artery, in the left and right carotid arteries, in the
right but not in the left subclavian arteries nor in the dorsal
aorta (Fig. 6F, arrowhead). The ligamentum arteriosum,
which derives from the ductus arteriosis, was strongly
stained in the adult heart (Fig. 6F, red arrow).
Other NCC derivatives, such as the stromal components
of the thyroid and parathyroid glands (not shown), the
thymus (see Fig. 6B), and the adrenal gland (Fig. 7A–C),
were labeled as well as the melanocytes (Fig. 7D and E).
The adrenal anlagen was stained with -galactosidase at
E12.5 (not shown). The positive cells found in the anlagen
were most likely chromaffin cell precursors, as deduced
from their typical location in the medullar compartment of
the adrenal glands at E16.5 (Fig. 7A). Indeed, these cells
expressed both -galactosidase and chromogranins (Fig. 7B
and C). The sensory innervation of the gland is also stained
(Fig. 7A, arrow). In adult skin, the melanocytes, revealed by
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their intense pigmentation in the hair matrix of the follicles
(Fig. 7E), were heavily stained with -galactosidase as well
as those in interaction with the basement membrane of the
epidermis (Fig. 7D, arrow) or in the dermis.
Comparison between Ht-PA-Cre and Wnt1-Cre line to
target NCC derivatives
The Wnt1-Cre line described by McMahon and cowork-
ers (Danielian et al., 1998) has been used to determine the
fate of the mammalian cranial and cardiac NCC (Chai et al.,
2000; Jiang et al., 2000). We compared the Wnt1-Cre with
the Ht-PA-Cre line for each of their targeted derivatives. In
whole-mount stained embryos, it is obvious that the two
types of markers are able to target the cephalic mesenchyme
and the cells of branchial arches as shown in Fig. 8A and B
(arrowheads; Wnt1-Cre/R26R at E9.75) and in Fig. 2C and
D (Ht-PA-Cre/R26R E9–E9.5). In E12–E12.5 whole-mount
embryos, a similar staining in cranofacial structures and the
developing sensory nervous system was observed for the
two types of embryos (Fig. 8D and E). A major difference
between the two embryos, however, is that Wnt1-Cre can
target the dorsal NT as shown on sagittal sections at E9.75
(Fig. 8B and C, arrows) and at E12.5 (Fig. 8E and G,
arrows), whereas the Ht-PA-Cre line never targeted this
structure (Fig. 2C and G, arrow; Fig. 8D and F). In trans-
verse sections at the trunk level, it appeared that the ventral
and dorsal roots as well as the sensory ganglia and the
developing muscular and cutaneous innervation are labeled
in the Ht-PA-Cre/R26R and Wnt1-Cre/R26R (Fig. 8H and
I). However, it was clear that only the Wnt1-Cre/R26R
embryo exhibited a strong staining in the dorsal NT (black
arrow) and to a lesser extent in the mantle layer of the
intermediate NT, and the floor plate (red arrow and arrow-
head, respectively). An extensive comparison of the stained
derivatives in the head was made for these two transgenic
lines (Fig. 9), showing that they expressed -galactosidase
in the NCC-derived glial and neuronal cells of the sensory
nervous system as well as in the choroid plexuses and
pericytes (Etchevers et al., 2001). NCC-derived mesenchy-
mal derivatives are similarly stained, including the cephalic
mesenchyme rostral to the mesencephalon, the perioptic
mesenchyme, and that of maxillary process. During the
course of the heart development and in the adult, the labeled
cells found in our Ht-PA-Cre/R26R animals (see Fig. 6)
were similar to those described for the Wnt1-Cre/R26R
animals (Jiang et al., 2000). In addition, a similar labeling of
the enteric nervous system throughout its development was
observed for the two types of animals (not shown).
Fig. 4. Ht-PA-Cre-dependent expression of -galactosidase in the vagal
region of a Theiler Stage 15 embryo. Transverse sections of an embryo at
the level of pharynx (A, B), tracheal diverticulum (C), and various levels
of the gut (D and E). (A) Labeled cells are located in the space between the
pharyngeal endoderm and the splanchnic mesoderm (arrow), and they are
not round on the perichordal mesenchyme around notochord (arrowhead).
(B) Cells that emerge from the NT and migrate between the cervical
myotome and the ectoderm (arrow) are labeled. Expressing cells are also
found closely apposed to the right and left dorsal aorta (C–F, arrowhead)
and they enter the primitive gut (E and F, arrow). (G) Schematic repre-
sentation of the section levels and distribution of labeled cells on the
embryo (red with different intensities for cell density). Scale bar in (A)
corresponds to 100 m. p, pharynx; h, heart; td, tracheal diverticulum; fg,
foregut; mg, midgut; lcv, left cardinal vein; rcv, right cardinal vein; lAo,
left aorta; rAo, right aorta.
Fig. 5. Distribution of the labeled cells in the E12.5, E16.5 gut, and in the adult
gut. Whole-mount stained E12.5 (A); the arrowhead shows the front of the
labeled cells and the arrow indicates the pelvic mesenchyme which is heavily
stained. Details of the organization of labeled cells into ganglia in whole-
mount stained E16.5 gut (B and D) and on sections (C and E) at the level of
the duodenum (B and C) and the colon, ileum, and cecum (D and E). The
insert in (B) and (D) represents a higher magnification view of the staining at
the level of duodenum and the colon, respectively. Whole-mount stained adult
gut reveals the organization of labeled cells as a network as shown at the level
of the jejunum (F). On transverse sections of the jejunum (G), the outer
myenteric (arrow) and inner submucosal ganglia (arrowhead) express -ga-
lactosidase. Scale bar in (A), (B), and (F) corresponds to 1 mm. Scale bar in
(C), (G), and the insert of (B) and (F) represents 100 m. cs, cecum swelling;
il, ileum; co, colon; ce, cecum; st, stomach.
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Fig. 6. Ht-PA-Cre-dependent -galactosidase expression in NCC-derived cardiac derivatives. (A) Transverse section of a Theiler Stage 15 embryo at the level
where labeled cells (arrow) are seen along the endoderm in the aortic sac. (B and C) On transverse section of a E12.5 embryo, labeled cells are shown around
the thymic primordium and are located at the conotroncus region, the pulmonary trunk, and in the wall of the aorta and innominate artery (arrow in B). On
whole-mount stained E16.5 (D) and adult heart (F), extensive staining of the ascending aorta, the arch of the aorta, the left and right carotid arteries, and right
subclaviar artery is observed as well as the sensory innervation (black arrow in D and F). (E) Transverse section of a E16.5 heart reveals the localization
of labeled cells in the subendothelial layer of the pulmonary trunk and of the aortic valve, whereas the endothelium and the wall of the aorta are unlabeled.
Some cells in the muscular part of the interventricular septum are also stained. Sg, sympathetic ganglia; inn, innominate artery; th, thymus primordium; du,
ductus arteriosis; Ao, aorta; dAo, dorsal aorta; pt, pulmonary trunk; rv, right ventricule; ivs, interventricular septum; Aov, aortic valve; ct, conotruncus; lca
and rca, left and right carotid arteries; lsca and rsca, right and left subclavian arteries; aAo and dAo, ascending and descending aorta. The ligamentum
arteriosum (red arrow). Scale bar in (A), (B), and (E) corresponds to 200 M. Scale bar in (D) and (F) corresponds to 1 mm.
Fig. 7. Ht-PA-Cre-dependent -galactosidase expression in adrenal gland and melanocytes. An intense labelling of the medulla is observed on E16.5 adrenal
gland (A) as well as on the sensory innervation of the cortex (arrow). In the adult adrenal gland (B and C), the -galactosidase-expressing cells (B and C)
correspond to chromaffin cells as revealed by a colocalization of the anti-chromogranin A and B immunostaining (C). Transverse section of the skin dissected
from the back of adult mice (D and detail of a hair follicle in E) where sensory nerves (arrowhead) and pigmented melanocytes located close to the basement
membrane of the epidermis and in the hair matrix of follicles (arrows) are heavily stained for -galactosidase. Scale bar in (A) represents 500 m, and in
(B) and (E) corresponds to 50 m. Scale bar in (D) corresponds to 100 m. e, epidermis; d, dermis; h, hypodermis; m, muscular layer.
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Discussion
Specific expression of the transgene in the NCC
derivatives
We have generated transgenic mouse lines that express
the Cre recombinase under the control of the proximal 3-kb
promoter sequences of human tissue plasminogen activator.
By crossing the transgenic founder animals with ROSA26
Cre reporter mice, we observed that the -galactosidase was
expressed in NCC-derived tissues. In addition to marking
migratory cells, this indicates that the transgene is func-
tional to promote Cre-dependent DNA recombination and
that the proximal 3-kb Ht-PA promoter sequence contains
information to be activated in NCC as previously observed
(Theuring et al., 1995). We observed that, depending on the
founders, the transgene was also expressed in other tissues
that are not from a neural crest origin. These differences
Fig. 8. Comparison of -galactosidase expression in Ht-PA-Cre/R26R and in Wnt1-Cre/R26R embryos. (A–C) On whole-mount stained Wnt1-Cre/R26R
embryo at E9.75 and on sagittal sections (B and C), the cephalic mesenchyme and migratory NCC in the branchial arches (arrowheads) are heavily stained
as well as the dorsal NT (arrows). Whole-mount stained Ht-PA-Cre/R26R embryos (D and F) at E12 and Wnt1-Cre/R26R embryos at E12.5 (E and G)
revealed that the craniofacial structures as well as the developing muscular and cutaneous innervation were heavily stained in the two types of embryos. (F)
and (G) are dorsal view of the embryos showed in (D) and (E). The neural tube and CNS are stained only on Wnt1-Cre/R26R embryos. In (I) and (H), on
200-m-thick transverse sections, the dorsal NT (black arrows), intermediate NT (red arrow), and the floor plate (red arrowhead) are labeled in
Wnt1-Cre/R26R embryos (I), whereas these structures are never stained in Ht-PA-Cre/R26R embryos at E12.5 (H).
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among the founders analyzed probably reflects the effect of
the integration site into the genome on the modulation of the
3-kb Ht-PA promoter activity. In the Ht-PA-Cre/R26R an-
imals derived from the founder #116, we observed a specific
expression of the reporter gene in the NCC-derived tissues.
Only one ectopic site of -galactosidase expression was
found in the mesenchyme of the limb at E12.5, a non-NCC-
derived tissue. In the adult, the stained cells in the limb were
detected as a minor component of the periostum and ten-
dons (not shown) that can be easily distinguished from the
NCC-derived labeled cells. The Ht-PA promoter has been
suggested to be activated at sites of tissue remodeling
(Theuring et al., 1995). An extensive tissue remodelling
occurs in the limb at E12.5 that could explain the localized
expression of -galactosidase found in Ht-PA-Cre/R26R
embryos. Therefore, in the line #116, the Ht-PA-Cre trans-
gene is efficiently and almost specifically activated in NCC
and their derivatives. In contrast to various promoters pre-
Fig. 9. Comparison of -galactosidase expression in the head for Ht-PA-Cre/R26R and Wnt1-Cre/R26R E12.5 embryos. (Left panel) Listing of head
structures targeted by Ht-PA-Cre/R26R and Wnt1-Cre/R26R. (Right panel) Schematic representation of the contribution of labeled cells to form head
structures at various rostrocaudal levels in Ht-PA-Cre/R26R (red) and Wnt1-Cre/R26R (blue).
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viously used to target NCC derivatives by a Cre-dependent
DNA recombination, such as Krox20 (Voiculescu et al.,
2000), Pax-3 (Li et al., 2000), or P0 promoters (Yamauchi
et al., 1999; Feltri et al., 1999), the Ht-PA promoter activity
appears not to be restricted to specific NCC subpopulations
but rather behaves as a pan-NCC marker of craniofacial
structures, peripheral neuroblasts, and glial precursors, as
well as neuroendocrine cells all along axial levels.
Targeting of neural crest cells when they are migratory
The earliest expression of the -galactosidase in Ht-PA-
Cre/R26R embryos starts at Theiler Stage 12 among mes-
enchymal cells in the cephalic region that appear distally
from the NT. It is difficult to discern whether NCC should
have been detected earlier and hence proximal to the NT. A
delay between the induction of the Ht-PA promoter and the
expression of -galactosidase may arise from the Cre-de-
pendent DNA recombination at the ROSA26 locus. On
plausible explanation of this phenomenon is that -galac-
tosidase is observed only once these early cephalic NCC
have already dispersed far from the NT. In the trunk, labeled
NCC are visualized close to the neural tube, suggesting that
they stay in the so-called staging area before they actively
migrate (Weston, 1991). Subsequently, the Ht-PA promoter
targets a large variety of crest-derived cells, such as cranial,
vagal, cardiac, and trunk crest cells and their derivatives. In
addition, we have observed that, in our transgenic Ht-PA-
Cre line #116, the promoter is not activated in the NT.
Therefore, the transgene does not mark premigratory NCC
or other cells in the CNS. Rather, this promoter is specifi-
cally activated in NCC when they begin to migrate. This is
consistent with previous observations showing that migrat-
ing NCC express tissue plasminogen activator (Valinsky
and Le Douarin, 1985; Menoud et al., 1989; Erickson and
Isseroff, 1989) and the Ht-PA promoter activity in vivo in
NCC (Theuring et al., 1995).
Ht-PA-Cre expression in the developing gut: a tool to
investigate enteric nervous system ontogeny and function
The Ht-PA-Cre line #116 appears to be a powerful tool
to mark NCC and to analyze their derivatives. As an exam-
ple, we have further investigated the localization of cephalic
and vagal NCC in the early embryo and later during the
development of the gut. Neural crest-derived cells are
known to give rise to both neurons and glial cells of the
enteric nervous system (Le Douarin, 1982; Ciment and
Weston, 1983; Young and Newgreen, 2001). Several anal-
yses have investigated the contribution of vagal and sacral
NCC to the gut, and how the mammalian and avian enteric
nervous system develops (Rothman and Gershon, 1982;
Pomeranz et al., 1991; Serbedzija et al., 1991; Kapur et al.,
1992; Rothman et al., 1993; Serbedzija and McMahon,
1997; Taraviras and Pachnis, 1999; Kapur, 2000; Burns and
Le Douarin, 1998, 2001). The migratory pathways of NC
cells in the developing gut have been characterized in the
chicken embryo (Thiery et al., 1982; Tucker et al., 1986),
but they are poorly understood in mammals. In our model,
we can mark migratory NCC as soon as they escape from
the NT all along the axis of the embryo. By comparing the
location of labeled cells with those defined in the avian
embryo, we observed similarities and differences. Murine
vagal NCC, like their avian counterparts, were found lo-
cated laterally along the ectoderm and at the apex of the
pharynx and avoided the space around the notochord. How-
ever, in contrast to avian embryo, they were additionally
seen located in the sclerotome. This difference in the path-
ways followed in these two species may suggest some
variation in the requirement of particular guidance cues or
mesenchyme extracellular matrix for the migration of the
vagal NCC.
Later during the development of the gut, the enteric
nervous system is heavily stained. The staining illustrates
the distinct organization and density of the enteric ganglia
from the proximal to distal part of the gut, which correlates
with the specific control of the contractility of the intrinsic
smooth muscles and of the activity of secretory glands
associated with the function of the gastrointestinal tract
(Furness and Costa, 1987; Gershon, et al., 1994). This
topological organization and its function could be further
investigated in normal and pathological conditions, taking
advantage of our transgenic line.
Ht-PA-Cre line a good tool to target conditional
mutations in NCC derivatives
Among the transgenic lines available, the closest to our
line in term of its ability to target all the NCC derivatives is
the Wnt1-Cre line described by McMahon and coworkers
(Echelard et al., 1994; Danielian et al., 1998). The use of
Wnt1-Cre line has allowed the detailed analysis of the fate
of cranial NCC during tooth and skull vault development
and the fate of cardiac NCC (Chai et al., 2000; Jiang et al.,
2000, 2002). A comparison between Ht-PA-Cre/R26R and
Wnt1-Cre/R26R embryos revealed that the two lines simi-
larly target the NCC-derived structures, such as the cranio-
facial structures, the cardiac derivatives, the peripheral and
enteric nervous systems, as well as the endocrine deriva-
tives. However, a difference between the Ht-PA and the
Wnt1 promoter activity in transgenic animals concerns the
targeting of the NT. The Wnt1 promoter is activated in the
dorsal NT during early embryogenesis (Theiler Stage 11).
Thus, the use of Wnt1-Cre line allows all the tissues derived
from the dorsal NT to be targeted, including the NCC
derivatives, but also the dorsal part of the CNS. The Ht-PA
promoter in our transgenic line does not label dorsal NT nor
the premigratory NCC (Theiler Stage 12). We suggest that
this characteristic of the Ht-PA-Cre line renders it more
specific for NCC than the Wnt1-Cre line. Because of its
specificity, the Ht-PA-Cre line allows a more precise ma-
nipulation of gene expression in NCC without targeting the
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CNS itself. The difference in the ability of the Ht-PA and
Wnt1 promoters to affect the NT, in addition to NCC, may
be crucial for the analysis of the control of gene expression
involved in the development of NT, NCC, and their deriv-
atives. For example, the inactivation of such genes in the
dorsal NT could produce strong early defects in the CNS
leading to morphological abnormalities and therefore im-
pairing the analysis of NCC-specific defects at later stages.
In this respect, this new Ht-PA-Cre transgenic line consti-
tutes a unique and useful model which is able to specifically
target conditional mutation in the NCC derivatives.
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